CN114478670B - A method for synthesizing On-DNA β-substituted ketone compounds - Google Patents
A method for synthesizing On-DNA β-substituted ketone compounds Download PDFInfo
- Publication number
- CN114478670B CN114478670B CN202011151383.4A CN202011151383A CN114478670B CN 114478670 B CN114478670 B CN 114478670B CN 202011151383 A CN202011151383 A CN 202011151383A CN 114478670 B CN114478670 B CN 114478670B
- Authority
- CN
- China
- Prior art keywords
- equivalents
- dna
- compound
- hours
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 ketone compounds Chemical class 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 30
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 33
- 150000001728 carbonyl compounds Chemical class 0.000 claims abstract description 19
- 239000004327 boric acid Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 23
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 238000003786 synthesis reaction Methods 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- MFGOFGRYDNHJTA-UHFFFAOYSA-N 2-amino-1-(2-fluorophenyl)ethanol Chemical compound NCC(O)C1=CC=CC=C1F MFGOFGRYDNHJTA-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- HUCVOHYBFXVBRW-UHFFFAOYSA-M caesium hydroxide Inorganic materials [OH-].[Cs+] HUCVOHYBFXVBRW-UHFFFAOYSA-M 0.000 claims description 6
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 6
- 125000001544 thienyl group Chemical group 0.000 claims description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 2
- 239000000178 monomer Substances 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- 230000000379 polymerizing effect Effects 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract description 19
- 125000003118 aryl group Chemical group 0.000 abstract description 9
- 229910052763 palladium Inorganic materials 0.000 abstract description 8
- 239000003054 catalyst Substances 0.000 abstract description 7
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 22
- 125000000217 alkyl group Chemical group 0.000 description 13
- 235000010338 boric acid Nutrition 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 125000001424 substituent group Chemical group 0.000 description 9
- 229910052736 halogen Inorganic materials 0.000 description 6
- 150000002367 halogens Chemical class 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 150000002611 lead compounds Chemical class 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- 125000003107 substituted aryl group Chemical group 0.000 description 4
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000012917 library technology Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 125000005493 quinolyl group Chemical group 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 125000005017 substituted alkenyl group Chemical group 0.000 description 3
- 125000000547 substituted alkyl group Chemical group 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 125000000335 thiazolyl group Chemical group 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Natural products P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical group [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 2
- LMBWSYZSUOEYSN-UHFFFAOYSA-N diethyldithiocarbamic acid Chemical compound CCN(CC)C(S)=S LMBWSYZSUOEYSN-UHFFFAOYSA-N 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 125000005059 halophenyl group Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 125000005647 linker group Chemical group 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 150000003003 phosphines Chemical class 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 1
- VSTXCZGEEVFJES-UHFFFAOYSA-N 1-cycloundecyl-1,5-diazacycloundec-5-ene Chemical compound C1CCCCCC(CCCC1)N1CCCCCC=NCCC1 VSTXCZGEEVFJES-UHFFFAOYSA-N 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 125000005619 boric acid group Chemical class 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical group OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940116901 diethyldithiocarbamate Drugs 0.000 description 1
- FDPIMTJIUBPUKL-UHFFFAOYSA-N dimethylacetone Natural products CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229950004394 ditiocarb Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000006357 methylene carbonyl group Chemical group [H]C([H])([*:1])C([*:2])=O 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- PBDBXAQKXCXZCJ-UHFFFAOYSA-L palladium(2+);2,2,2-trifluoroacetate Chemical compound [Pd+2].[O-]C(=O)C(F)(F)F.[O-]C(=O)C(F)(F)F PBDBXAQKXCXZCJ-UHFFFAOYSA-L 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical class C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
技术领域Technical field
本发明属于编码化合物库技术领域,具体涉及一种DNA编码化合物库中构建On-DNAβ取代酮类化合物的方法。The invention belongs to the technical field of encoded compound libraries, and specifically relates to a method for constructing On-DNA β-substituted ketone compounds in a DNA-encoded compound library.
背景技术Background technique
在药物研发,尤其是新药研发中,针对生物靶标的高通量筛选是快速获得先导化合物的主要手段之一。然而,基于单个分子的传统高通量筛选所需时间长、设备投入巨大、库化合物数量有限(数百万),且化合物库的建成需要数十年的积累,限制了先导化合物的发现效率与可能性。近年来出现的DNA编码化合物库技术(WO2005058479、WO2018166532、CN103882532),结合了组合化学和分子生物学技术,在分子水平上将每个化合物加上一个DNA标签,并能在极短的时间内合成高达亿级的化合物库,成为下一代化合物库筛选技术的趋势,并开始在制药行业广泛应用,产生了诸多积极的效果(Accounts of ChemicalResearch,2014,47,1247-1255)。In drug research and development, especially new drug research and development, high-throughput screening of biological targets is one of the main means to quickly obtain lead compounds. However, traditional high-throughput screening based on single molecules requires a long time, huge equipment investment, limited number of library compounds (millions), and the construction of compound libraries requires decades of accumulation, which limits the efficiency and efficiency of lead compound discovery. possibility. The DNA-encoded compound library technology that has emerged in recent years (WO2005058479, WO2018166532, CN103882532) combines combinatorial chemistry and molecular biology technology to add a DNA tag to each compound at the molecular level, and can be synthesized in a very short time Compound libraries of up to 100 million levels have become the trend of next-generation compound library screening technology, and have begun to be widely used in the pharmaceutical industry, producing many positive effects (Accounts of Chemical Research, 2014, 47, 1247-1255).
DNA编码化合物库通过组合化学快速产生巨型化合物库,并且能高通量地筛选出先导化合物,使得先导化合物的筛选变得前所未有的快捷和高效。构建DNA编码化合物库的挑战之一就是需要在DNA上高收率地合成具有化学多样性的小分子。由于DNA需要在一定的条件下(溶剂、pH、温度、离子浓度)才能维持稳定,同时应用于DNA编码化合物库构建的On-DNA反应还需要有较高的产率。因此DNA上进行的化学反应(简称On-DNA反应)的试剂种类、反应种类、反应条件直接影响到DNA编码化合物库的丰富度和可选择性。从而开发能够与DNA兼容的化学反应也成为目前DNA编码化合物库技术的长期探索和研究方向,也直接影响了DNA编码化合物库的应用及商业价值。DNA-encoded compound libraries quickly generate giant compound libraries through combinatorial chemistry, and can screen lead compounds in high-throughput, making the screening of lead compounds faster and more efficient than ever before. One of the challenges in constructing DNA-encoded compound libraries is the need to synthesize chemically diverse small molecules on DNA with high yields. Since DNA needs to be stable under certain conditions (solvent, pH, temperature, ion concentration), On-DNA reactions used in the construction of DNA-encoded compound libraries also need to have a higher yield. Therefore, the types of reagents, reaction types, and reaction conditions of chemical reactions performed on DNA (referred to as On-DNA reactions) directly affect the richness and selectivity of the DNA-encoded compound library. Therefore, the development of chemical reactions compatible with DNA has become a long-term exploration and research direction of current DNA-encoded compound library technology, which also directly affects the application and commercial value of DNA-encoded compound libraries.
α,β不饱和羰基化合物和硼酸化合物通过共轭加成在羰基的β位形成sp2杂化的碳原子连接位点,可以丰富药物化合物的拓扑结构,将这类β取代酮类化合物引入到DNA编码化合物库中能进一步扩展化合物库的多样性,有利于提高筛选到有效化合物的概率。然而目前并没有报道通过On-DNAα,β-不饱和羰基化合物合成On-DNAβ取代酮类化合物的方法。因此希望开发一种新的适用于大批量多孔板操作的On-DNAβ取代酮类化合物的合成方法,以增加DNA编码化合物库的多样性,进一步提升DNA编码化合物库技术的应用价值。α,β unsaturated carbonyl compounds and boronic acid compounds form sp 2 hybridized carbon atom connection sites at the β position of the carbonyl group through conjugate addition, which can enrich the topological structure of pharmaceutical compounds and introduce such β-substituted ketone compounds into The DNA-encoded compound library can further expand the diversity of the compound library, which is helpful to increase the probability of screening effective compounds. However, there is currently no report on the synthesis of On-DNAβ-substituted ketones through On-DNAα,β-unsaturated carbonyl compounds. Therefore, it is hoped to develop a new synthesis method for On-DNAβ-substituted ketone compounds suitable for large-scale multi-well plate operation to increase the diversity of DNA-encoded compound libraries and further enhance the application value of DNA-encoded compound library technology.
发明内容Contents of the invention
为了解决上述问题,我们开发了一种原料稳定存储、反应条件温和、底物普适性好,对DNA损伤小,适合于使用多孔板进行批量操作的DNA编码化合物库的合成方法,可以快速将On-DNAα,β-不饱和羰基化合物通过一步反应转化为On-DNAβ取代酮类化合物。In order to solve the above problems, we have developed a method for synthesizing a DNA-encoded compound library with stable storage of raw materials, mild reaction conditions, good substrate versatility, little damage to DNA, and suitable for batch operation using multi-well plates, which can quickly On-DNAα,β-unsaturated carbonyl compounds are converted into On-DNAβ substituted ketones through a one-step reaction.
本发明采用的技术方案如下:The technical solutions adopted by the present invention are as follows:
一种合成On-DNAβ取代酮类化合物的方法:该方法以On-DNAα,β不饱和羰基化合物为原料,在钯催化剂、碱存在下,与硼酸化合物反应得到On-DNAβ取代酮类化合物;其中,On-DNAα,β不饱和羰基化合物的结构式为硼酸化合物的结构式为:/>On-DNAβ取代酮类化合物的结构式为:/> A method for synthesizing On-DNAβ-substituted ketone compounds: the method uses On-DNAα,β unsaturated carbonyl compounds as raw materials, reacts with boric acid compounds in the presence of a palladium catalyst and a base to obtain On-DNAβ-substituted ketone compounds; wherein , the structural formula of On-DNAα,β unsaturated carbonyl compound is The structural formula of boric acid compound is:/> The structural formula of On-DNAβ substituted ketone compounds is:/>
其中,结构式中DNA包含由人工修饰的和/或未修饰的核苷酸单体聚合得到的单链或双链的核苷酸链,该核苷酸链通过一个或多个化学键或基团与化合物剩余部分相连;所述DNA的长度为10~200bp。Wherein, the DNA in the structural formula includes a single-stranded or double-stranded nucleotide chain obtained by polymerizing artificially modified and/or unmodified nucleotide monomers, and the nucleotide chain is connected to the nucleotide chain through one or more chemical bonds or groups. The remaining parts of the compound are connected; the length of the DNA is 10 to 200 bp.
其中,结构式中的DNA与R1或R3通过一个化学键或多个化学键连接。一个化学键时,是指结构式中的DNA与R1或R3直接相连;多个化学键时,指结构式中的DNA与R1或R3之间间隔多个化学键相连,比如,DNA与R1或R3之间通过一个亚甲基(-CH2-)相连,即通过两个化学键连接;或DNA与R1或R3之间通过一个羰基(-CO-)连接DNA的氨基,也是通过两个化学键连接;或DNA与R1或R3通过一个亚甲基羰基(-CH2CO-)连接DNA的氨基,也是通过三个连续的化学键连接。Among them, the DNA in the structural formula and R 1 or R 3 are connected through one chemical bond or multiple chemical bonds. When there is one chemical bond, it means that the DNA in the structural formula is directly connected to R 1 or R 3 ; when there are multiple chemical bonds, it means that there are multiple chemical bonds between the DNA and R 1 or R 3 in the structural formula. For example, DNA is connected to R 1 or R 3. R 3 are connected through a methylene group (-CH 2 -), that is, connected through two chemical bonds; or DNA and R 1 or R 3 are connected through a carbonyl group (-CO-) to the amino group of DNA, also through two chemical bonds. Connected by a chemical bond; or DNA and R 1 or R 3 are connected to the amino group of DNA through a methylene carbonyl group (-CH 2 CO-), which is also connected through three consecutive chemical bonds.
R1选自分子量1000以下与DNA和羰基碳原子直接相连的基团或者不存在;R 1 is selected from a group with a molecular weight of less than 1000 that is directly connected to DNA and carbonyl carbon atoms or does not exist;
R2选自分子量1000以下与烯基碳原子直接相连的基团;R 2 is selected from a group with a molecular weight of less than 1000 directly connected to an alkenyl carbon atom;
R3选自分子量1000以下与DNA和烯基碳原子直接相连的基团或者不存在;R 3 is selected from a group with a molecular weight of less than 1000 that is directly connected to DNA and alkenyl carbon atoms or does not exist;
R4选自分子量1000以下与羰基碳原子直接相连的基团;R 4 is selected from a group with a molecular weight of less than 1000 that is directly connected to the carbonyl carbon atom;
R5选自氢或分子量1000以下与烯基碳原子直接相连的基团;R 5 is selected from hydrogen or a group with a molecular weight of less than 1000 directly connected to the alkenyl carbon atom;
R6选自分子量1000以下与硼酸化合物中硼原子直接相连的基团;R 6 is selected from a group with a molecular weight of less than 1000 that is directly connected to the boron atom in the boric acid compound;
或R5分别与R1或R4成环。Or R 5 forms a ring with R 1 or R 4 respectively.
作为优选:所述R1、R2、R3、R4分别选自烷基、取代烷基、芳香基或取代芳香基;其中,所述烷基为C1~C20烷基或C3~C8环烷基;取代烷基的取代基的数量为一个或多个;取代烷基的取代基是相互独立的选自卤素、硝基、烷氧基、卤代苯基、苯基、烷基苯基、杂环基中的一种或多种;所述芳香基选自吡啶基、喹啉基、噻唑基、噻吩基或苯基;取代芳香基的取代基的数量为一个或多个,取代芳香基的取代基是相互独立的选自卤素、氰基、硝基、烷氧基、C1~C20烷基、三氟甲基中的一种或多种;Preferably: R 1 , R 2 , R 3 and R 4 are respectively selected from alkyl, substituted alkyl, aryl or substituted aryl; wherein, the alkyl is C 1 to C 20 alkyl or C 3 ~C 8 cycloalkyl; the number of substituents of the substituted alkyl group is one or more; the substituents of the substituted alkyl group are independently selected from halogen, nitro, alkoxy, halophenyl, phenyl, One or more of alkylphenyl and heterocyclyl; the aromatic group is selected from pyridyl, quinolyl, thiazolyl, thienyl or phenyl; the number of substituents of the substituted aromatic group is one or more Each, the substituents of the substituted aromatic group are independently selected from one or more types of halogen, cyano, nitro, alkoxy, C 1 to C 20 alkyl, and trifluoromethyl;
所述R5选自氢、C1~C20烷基;The R 5 is selected from hydrogen and C 1 to C 20 alkyl;
所述R6选自烯基、取代烯基、芳香基或取代芳香基;所述烯基选自C2~C20烯基或C3~C8环烯基;取代烯基的取代基的数量为一个或多个,取代烯基的取代基是相互独立的选自卤素、氰基、硝基、烷氧基、C1~C20烷基、三氟甲基中的一种或多种;所述芳香基选自吡啶基、喹啉基、噻唑基、噻吩基或苯基;取代芳香基的取代基的数量为一个或多个,取代芳香基的取代基是相互独立的选自卤素、氰基、硝基、烷氧基、C1~C20烷基、三氟甲基中的一种或多种。The R 6 is selected from alkenyl, substituted alkenyl, aryl or substituted aryl; the alkenyl is selected from C 2 to C 20 alkenyl or C 3 to C 8 cycloalkenyl; the substituents of the substituted alkenyl are The number is one or more, and the substituents of the substituted alkenyl group are independently selected from one or more of halogen, cyano, nitro, alkoxy, C 1 to C 20 alkyl, and trifluoromethyl. ; The aryl group is selected from pyridyl, quinolyl, thiazolyl, thienyl or phenyl; the number of substituents of the substituted aryl group is one or more, and the substituents of the substituted aryl group are independently selected from halogen , one or more of cyano group, nitro group, alkoxy group, C 1 to C 20 alkyl group, and trifluoromethyl group.
进一步地:further:
所述的R1选自苯基、噻吩基;所述的R2选自苯基、C1~C6烷基;所述C1~C6烷基具体选自甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基、戊烷基、己烷基;The R 1 is selected from phenyl and thienyl; the R 2 is selected from phenyl, C 1 to C 6 alkyl; the C 1 to C 6 alkyl is specifically selected from methyl, ethyl, n- Propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl;
所述的R3选自苯基、噻吩基;所述的R4选自苯基、C1~C6烷基;所述C1~C6烷基具体选自甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基、戊烷基、己烷基;The R 3 is selected from phenyl and thienyl; the R 4 is selected from phenyl, C 1 to C 6 alkyl; the C 1 to C 6 alkyl is specifically selected from methyl, ethyl, n- Propyl, isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl;
所述R5选自氢、C1~C6烷基;或R5分别与R1或R4成环;所述C1~C6烷基具体选自甲基、乙基、正丙基、异丙基、正丁基、异丁基、叔丁基、戊烷基、己烷基;The R 5 is selected from hydrogen, C 1 to C 6 alkyl; or R 5 forms a ring with R 1 or R 4 respectively; the C 1 to C 6 alkyl is specifically selected from methyl, ethyl, n-propyl , isopropyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl;
所述的R6选自苯基、三氟甲基取代的苯基、C1~C6烷氧基取代的苯基、C3~C8不饱和环烷基;所述C1~C6烷氧基具体选自甲氧基、乙氧基、丙氧基、丁氧基、戊烷氧基、己烷氧基;The R 6 is selected from phenyl, trifluoromethyl-substituted phenyl, C 1 to C 6 alkoxy-substituted phenyl, C 3 to C 8 unsaturated cycloalkyl; the C 1 to C 6 The alkoxy group is specifically selected from methoxy, ethoxy, propoxy, butoxy, pentyloxy, and hexyloxy;
作为优选:所述On-DNAα,β-不饱和羰基化合物具体选自:Preferably: the On-DNAα,β-unsaturated carbonyl compound is specifically selected from:
所述的硼酸化合物具体选自: The boric acid compound is specifically selected from:
一种合成On-DNAβ取代酮类化合物的方法,该方法包括以下步骤:向摩尔当量为1,摩尔浓度为0.5-5mM的On-DNAα,β-不饱和羰基化合物溶液中,加入10~1000倍摩尔当量的硼酸化合物、10~1000倍摩尔当量的碱,再加入0.1-100倍摩尔当量的钯催化剂,在10℃~100℃下反应0.1~24小时。A method for synthesizing On-DNAβ-substituted ketone compounds. The method includes the following steps: adding 10 to 1000 times to an On-DNAα,β-unsaturated carbonyl compound solution with a molar equivalent of 1 and a molar concentration of 0.5-5mM. Molar equivalents of a boric acid compound, 10 to 1000 molar equivalents of a base, and then 0.1 to 100 molar equivalents of a palladium catalyst are added, and the reaction is carried out at 10°C to 100°C for 0.1 to 24 hours.
进一步地,所述碱选自硼酸钠、氢氧化锂、氢氧化钠、氢氧化钾、氢氧化铯、碳酸钠、碳酸钾、碳酸铯、磷酸钠、磷酸钾、磷酸氢钠、磷酸氢钾、N-甲基吗啉、三乙胺、二异丙基乙基胺、DBU(1,8-二氮杂二环十一碳-7-烯),4-二甲氨基吡啶,2,6-二甲基吡啶,N-甲基咪唑;优选地,所述碱为氢氧化铯。Further, the base is selected from the group consisting of sodium borate, lithium hydroxide, sodium hydroxide, potassium hydroxide, cesium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium phosphate, potassium phosphate, sodium hydrogen phosphate, potassium hydrogen phosphate, N-methylmorpholine, triethylamine, diisopropylethylamine, DBU (1,8-diazabicycloundec-7-ene), 4-dimethylaminopyridine, 2,6- Dimethylpyridine, N-methylimidazole; preferably, the base is cesium hydroxide.
进一步地,所述反应在溶剂中进行,溶剂为水、甲醇、乙醇、乙腈、二甲亚砜、无机盐缓冲液、有机酸缓冲液、有机碱缓冲液中任意一种或几种的含水混合溶剂;优选地,所述反应溶剂含水、二甲亚砜。Further, the reaction is carried out in a solvent, and the solvent is any one or aqueous mixture of several of water, methanol, ethanol, acetonitrile, dimethyl sulfoxide, inorganic salt buffer, organic acid buffer, and organic base buffer. Solvent; Preferably, the reaction solvent contains water and dimethyl sulfoxide.
进一步地,所述反应的钯催化剂为Pd2(dba)3、四三苯基膦钯、醋酸钯、三氟乙酸钯、单质钯(钯黑)、sSPhosPd-G2;优选地,所述钯催化剂为sSPhos-Pd-G2、醋酸钯或四三苯基膦钯。Further, the palladium catalyst used in the reaction is Pd 2 (dba) 3 , palladium tetrakis triphenylphosphine, palladium acetate, palladium trifluoroacetate, elemental palladium (palladium black), sSPhosPd-G2; preferably, the palladium catalyst It is sSPhos-Pd-G2, palladium acetate or tetrakis triphenylphosphine palladium.
进一步地,所述反应还需加入配体,配体的加入量为0.1-100摩尔当量,所述配体选自三苯基膦、三芳基取代膦、三环己基膦、三烷基取代膦或单芳基双烷基膦。优选地,所述加入配体的摩尔当量为0.5当量、2当量、5当量、10当量、15当量、20当量、30当量、50当量、80当量。Further, the reaction also requires the addition of ligands, the amount of ligands being added is 0.1-100 molar equivalents, and the ligands are selected from the group consisting of triphenylphosphine, triaryl-substituted phosphine, tricyclohexylphosphine, and trialkyl-substituted phosphine. or monoaryldialkylphosphine. Preferably, the molar equivalent of the added ligand is 0.5 equivalent, 2 equivalent, 5 equivalent, 10 equivalent, 15 equivalent, 20 equivalent, 30 equivalent, 50 equivalent, or 80 equivalent.
进一步地,所述反应的反应温度为10℃~100℃;优选地,反应温度为20℃、30℃、40℃、50℃、60℃、70℃、80℃、90℃、100℃。Further, the reaction temperature of the reaction is 10°C to 100°C; preferably, the reaction temperature is 20°C, 30°C, 40°C, 50°C, 60°C, 70°C, 80°C, 90°C, 100°C.
进一步地,所述反应的反应时间为0.5~24小时;优选地,反应时间为1小时、2小时、4小时、8小时、10小时、16小时、18小时、20小时。Further, the reaction time of the reaction is 0.5 to 24 hours; preferably, the reaction time is 1 hour, 2 hours, 4 hours, 8 hours, 10 hours, 16 hours, 18 hours, or 20 hours.
进一步地,所述方法中On-DNAα,β-不饱和羰基化合物的摩尔当量为1,硼酸化合物的摩尔当量为10~1000,碱的摩尔当量为10~1000;优选地,硼酸化合物的摩尔当量为50当量、100当量、200当量、300当量、400当量、500当量、600当量、800当量、1000当量;碱的摩尔当量为50当量、100当量、200当量、300当量、400当量、500当量、600当量、800当量、1000当量;钯催化剂的摩尔当量为0.5当量、1.5当量、2.5当量、3.5当量、5当量、10当量、20当量、40当量、80当量;最优选地,硼酸化合物的摩尔当量为100,碱的摩尔当量为100,钯催化剂的摩尔当量为2.5。Further, in the method, the molar equivalent of On-DNAα,β-unsaturated carbonyl compound is 1, the molar equivalent of the boric acid compound is 10-1000, and the molar equivalent of the base is 10-1000; preferably, the molar equivalent of the boric acid compound They are 50 equivalents, 100 equivalents, 200 equivalents, 300 equivalents, 400 equivalents, 500 equivalents, 600 equivalents, 800 equivalents, and 1000 equivalents; the molar equivalents of bases are 50 equivalents, 100 equivalents, 200 equivalents, 300 equivalents, 400 equivalents, and 500 equivalents. , 600 equivalents, 800 equivalents, 1000 equivalents; the molar equivalents of the palladium catalyst are 0.5 equivalents, 1.5 equivalents, 2.5 equivalents, 3.5 equivalents, 5 equivalents, 10 equivalents, 20 equivalents, 40 equivalents, 80 equivalents; most preferably, the boric acid compound The molar equivalents are 100, the molar equivalents of the base are 100, and the molar equivalents of the palladium catalyst are 2.5.
进一步地,所述方法用于批量的多孔板操作。Further, the method is used for batch multi-well plate operations.
进一步地,所述方法用于多孔板的DNA编码化合物库的合成。Further, the method is used for the synthesis of DNA-encoded compound libraries in multi-well plates.
本发明方法可以实现在DNA编码化合物库中通过On-DNAα,β-不饱和羰基化合物得到On-DNAβ取代酮类化合物,可广泛应用于各种On-DNAα,β-不饱和羰基底物,并且能大规模引入各种取代的硼酸类化合物作为合成模块。该方法产物单一,能够在有机溶剂/水相的混合水相中进行,操作简单,环境友好,适合使用多孔板进行的DNA编码化合物库的合成。The method of the invention can obtain On-DNAβ-substituted ketone compounds through On-DNAα,β-unsaturated carbonyl compounds in the DNA-encoded compound library, and can be widely used in various On-DNAα,β-unsaturated carbonyl substrates, and Various substituted boronic acid compounds can be introduced on a large scale as synthetic modules. This method has a single product, can be carried out in a mixed aqueous phase of organic solvent/water phase, is simple to operate, is environmentally friendly, and is suitable for the synthesis of DNA-encoded compound libraries using multi-well plates.
关于本发明的使用术语的定义:除非另有说明,本文中基团或者术语提供的初始定义适用于整篇说明书的该基团或者术语;对于本文没有具体定义的术语,应该根据公开内容和上下文,给出本领域技术人员能够给予它们的含义。Definitions of terms used in the present invention: Unless otherwise stated, the initial definition provided for a group or term in this article applies to the group or term in the entire specification; for terms that are not specifically defined in this article, it should be based on the disclosure content and context. , giving the meanings that those skilled in the art can give them.
“取代”是指分子中的氢原子被其它不同的原子或分子所替换。"Substitution" means that a hydrogen atom in a molecule is replaced by a different atom or molecule.
碳氢基团中碳原子含量的最小值和最大值通过前缀表示,例如,前缀(Ca~Cb)烷基表明任何含“a”至“b”个碳原子的烷基。因此,例如,C1~C20烷基是指包含1~20个碳原子的直链或支链的烷基。The minimum and maximum content of carbon atoms in a hydrocarbon group is indicated by a prefix, for example, the prefix (Ca~ Cb )alkyl indicates any alkyl group containing "a" to "b" carbon atoms. Thus, for example, a C 1 -C 20 alkyl group refers to a straight or branched chain alkyl group containing 1 to 20 carbon atoms.
烷基是指烷烃分子中H被取代形成的直链或支链的烃基,例如甲基CH3-,乙基CH3CH2-,亚甲基-CH2-。Alkyl refers to a linear or branched hydrocarbon group formed by substitution of H in an alkane molecule, such as methyl CH 3 -, ethyl CH 3 CH 2 -, and methylene -CH 2 -.
环烷基:是指H被取代形成的饱和或不饱和的环烷基;Cycloalkyl: refers to a saturated or unsaturated cycloalkyl group formed by H being substituted;
卤素:为氟、氯、溴或碘。Halogen: is fluorine, chlorine, bromine or iodine.
芳香基:是指芳香环上的部分H被取代得到的基团,例如吡啶基、喹啉基、噻唑基或苯基。Aryl group: refers to a group in which part of the H on the aromatic ring is substituted, such as pyridyl, quinolyl, thiazolyl or phenyl.
烷氧基:是指烷基与氧原子连接形成取代基,例如甲氧基为-OCH3。Alkoxy group: refers to an alkyl group connected to an oxygen atom to form a substituent, for example, methoxy group is -OCH 3 .
卤代苯基:是指苯基上的H被卤素取代而形成的基团。Halophenyl: refers to a group formed by replacing H on the phenyl group with halogen.
烷基苯基:是指苯基上的H被烷基取代而形成的基团。Alkylphenyl: refers to a group formed by replacing H on the phenyl group with an alkyl group.
杂环基:是带有至少一个选自O、S、N的3至8个原子的饱和或不饱和的单环或多环烃基。Heterocyclyl: a saturated or unsaturated monocyclic or polycyclic hydrocarbon group with at least one 3 to 8 atoms selected from O, S, and N.
显然,根据本发明的上述内容,按照本领域的普通技术知识和惯用手段,在不脱离本发明上述基本技术思想前提下,还可以做出其它多种形式的修改、替换或变更。Obviously, according to the above content of the present invention, according to the common technical knowledge and common means in the field, without departing from the above basic technical idea of the present invention, various other forms of modifications, replacements or changes can also be made.
以下通过实施例形式的具体实施方式,对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下的实例。凡基于本发明上述内容所实现的技术均属于本发明的范围。The above contents of the present invention will be further described in detail below through specific implementation methods in the form of examples. However, this should not be understood to mean that the scope of the above subject matter of the present invention is limited to the following examples. All technologies implemented based on the above contents of the present invention belong to the scope of the present invention.
附图说明Description of the drawings
附图1、2为本发明实施例2得到的32种On-DNAβ-芳基取代酮类化合物的转化率分布图。Figures 1 and 2 are conversion rate distribution diagrams of 32 On-DNA β-aryl substituted ketone compounds obtained in Example 2 of the present invention.
具体实施方式Detailed ways
本发明所用原料与设备均为已知产品,通过购买市售产品所得。The raw materials and equipment used in the present invention are all known products and are obtained by purchasing commercially available products.
本发明中,“室温”指20~25℃。In the present invention, "room temperature" means 20 to 25°C.
DMA:二甲基乙酰胺(Dimethylacetamide);DMA: Dimethylacetamide;
DMSO:二甲基亚砜。DMSO: dimethyl sulfoxide.
本发明中DNA-NH2是单链或双链DNA与接头基团形成的带有-NH2接头的DNA结构,例如WO2005058479中“compound1”的DNA-NH2结构。也例如下述的DNA结构:In the present invention, DNA-NH 2 is a DNA structure with an -NH 2 linker formed by single-stranded or double-stranded DNA and a linker group, such as the DNA-NH 2 structure of "compound1" in WO2005058479. For example, the following DNA structure:
其中,A为腺嘌呤,T为胸腺嘧啶,C为胞嘧啶,G为鸟嘌呤。Among them, A is adenine, T is thymine, C is cytosine, and G is guanine.
实施例1、On-DNAβ-芳基取代酮类化合物的合成Example 1. Synthesis of On-DNA β-aryl substituted ketone compounds
步骤1、On-DNAα,β-不饱和羰基化合物的合成Step 1. Synthesis of On-DNAα,β-unsaturated carbonyl compounds
将On-DNA芳基乙酮类化合物(A)溶解到250mM,pH=9.4的硼酸缓冲液中,配制成1mM浓度溶液(20μL,20nmol),向溶液中依次加入苯甲醛(4000nmol,200当量,200mM的DMSO溶液),氢氧化钾(10000nmol,500当量,1000mM的H2O溶液),混合均匀,30℃反应1小时。Dissolve On-DNA aryl ethyl ketone compound (A) into 250mM, pH=9.4 boric acid buffer, prepare a 1mM concentration solution (20μL, 20nmol), and add benzaldehyde (4000nmol, 200 equivalents, 200 equivalents) to the solution in sequence. 200mM DMSO solution), potassium hydroxide (10000nmol, 500 equivalents, 1000mM H 2 O solution), mix evenly, and react at 30°C for 1 hour.
将On-DNA芳基醛类化合物(B)溶解到250mM,pH=9.4的硼酸缓冲液中,配制成1mM浓度溶液(20μL,20nmol),向溶液中依次加入苯乙酮(2000nmol,100当量,200mM的DMSO溶液),氢氧化钾(6000nmol,300当量,1000mM的H2O溶液),混合均匀,30℃反应1小时。Dissolve On-DNA aryl aldehyde compound (B) into 250mM, pH=9.4 boric acid buffer, prepare a 1mM concentration solution (20μL, 20nmol), and add acetophenone (2000nmol, 100 equivalent, 200mM DMSO solution), potassium hydroxide (6000nmol, 300 equivalents, 1000mM H 2 O solution), mix evenly, and react at 30°C for 1 hour.
反应结束后进行乙醇沉淀:向反应后的溶液中加入总体积10%的5M的氯化钠溶液,然后继续加入总体积的3倍的无水乙醇,振荡均匀后,将反应置于干冰中冷冻0.5小时,之后在12000rpm的转速下低温(-4℃)离心半个小时,倒掉上清液,余下沉淀用去离子水溶解,即得到On-DNAα,β-不饱和羰基化合物(1、2)的溶液,通过酶标仪OD定量后,送LCMS确认化合物1、2的转化率分别为95%、83%。After the reaction, perform ethanol precipitation: add 10% of the total volume of 5M sodium chloride solution to the reacted solution, then continue to add 3 times the total volume of absolute ethanol, shake evenly, and freeze the reaction in dry ice. 0.5 hours, and then centrifuge at low temperature (-4°C) at 12000 rpm for half an hour, pour off the supernatant, and dissolve the remaining precipitate with deionized water to obtain On-DNA α, β-unsaturated carbonyl compounds (1, 2 ) solution was quantified by OD using a microplate reader and then sent to LCMS to confirm that the conversion rates of compounds 1 and 2 were 95% and 83% respectively.
步骤2、On-DNAβ-芳基取代酮类化合物的合成Step 2. Synthesis of On-DNAβ-aryl substituted ketones
将On-DNAα,β-不饱和羰基化合物(1、2)用去离子水配制成1mM浓度溶液(20μL,20nmol),向溶液中依次加入苯硼酸(2000nmol,100当量,200mM的DMA溶液),氢氧化铯(2000nmol,100当量,500mM的H2O溶液),Pd(OAc)2(50nmol,2.5当量,10mM的DMA溶液),PPh3(200nmol,10当量,50mM的DMA溶液);混合均匀,90℃,反应2小时。Prepare On-DNAα,β-unsaturated carbonyl compounds (1, 2) with deionized water to prepare a 1mM concentration solution (20μL, 20nmol), and add phenylboronic acid (2000nmol, 100 equivalents, 200mM DMA solution) to the solution in sequence. Cesium hydroxide (2000nmol, 100 equivalents, 500mM H 2 O solution), Pd(OAc) 2 (50nmol, 2.5 equivalents, 10mM DMA solution), PPh 3 (200nmol, 10 equivalents, 50mM DMA solution); mix well , 90°C, reaction for 2 hours.
反应结束后,向反应体系中加入二乙基二硫代氨基甲酸钠(DDTC)(2000nmol,100当量,400mM的H2O溶液),混合均匀,80℃,反应30分钟。反应结束后,向反应后的溶液中加入总体积10%的5M的氯化钠溶液,然后继续加入总体积的3倍的无水乙醇,振荡均匀后,将反应置于干冰中冷冻0.5小时,之后在12000rpm的转速下低温(-4℃)离心半个小时,倒掉上清液,余下沉淀用去离子水溶解,即得到On-DNAβ-芳基取代酮类化合物(1a、2a)的溶液,通过酶标仪OD定量后,送LCMS确认化合物1a、2a的转化率分别为84%、81%。After the reaction is completed, add sodium diethyldithiocarbamate (DDTC) (2000 nmol, 100 equivalents, 400 mM H 2 O solution) to the reaction system, mix evenly, and react at 80°C for 30 minutes. After the reaction is completed, add 10% of the total volume of 5M sodium chloride solution to the reacted solution, then continue to add 3 times the total volume of absolute ethanol, shake evenly, and freeze the reaction in dry ice for 0.5 hours. Then centrifuge at low temperature (-4°C) for half an hour at 12,000 rpm, discard the supernatant, and dissolve the remaining precipitate with deionized water to obtain a solution of On-DNA β-aryl substituted ketone compounds (1a, 2a). , after quantification by OD of a microplate reader, sent to LCMS to confirm that the conversion rates of compounds 1a and 2a were 84% and 81% respectively.
实施例2Example 2
按照实施例1方法,保持其他条件不变,将8种α,β-不饱和羰基化合物(1-8,如附图)和4种硼酸(a-d,如附图)的反应,得到32种On-DNAβ-芳基取代酮类化合物,具体反应产物见附图。According to the method of Example 1, keeping other conditions unchanged, 8 kinds of α, β-unsaturated carbonyl compounds (1-8, as shown in the accompanying drawing) and 4 kinds of boric acids (a-d, as shown in the accompanying drawing) are reacted to obtain 32 kinds of On -DNAβ-aryl substituted ketone compounds, the specific reaction products are shown in the attached figure.
综上所述,本发明通过控制反应时的溶剂、温度、pH等条件,可以将On-DNAα,β-不饱和羰基化合物和硼酸类化合物反应得到On-DNAβ-取代酮类化合物。该方法底物适用范围广,能够在有机溶剂/水相的混合水相中进行,操作简单,环境友好,适合使用多孔板进行的DNA编码化合物库的合成。In summary, the present invention can react On-DNAα,β-unsaturated carbonyl compounds and boric acid compounds to obtain On-DNAβ-substituted ketone compounds by controlling the solvent, temperature, pH and other conditions during the reaction. This method has a wide range of substrates and can be carried out in a mixed aqueous phase of organic solvent/water phase. It is simple to operate and environmentally friendly. It is suitable for the synthesis of DNA-encoded compound libraries using multi-well plates.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011151383.4A CN114478670B (en) | 2020-10-27 | 2020-10-27 | A method for synthesizing On-DNA β-substituted ketone compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011151383.4A CN114478670B (en) | 2020-10-27 | 2020-10-27 | A method for synthesizing On-DNA β-substituted ketone compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114478670A CN114478670A (en) | 2022-05-13 |
CN114478670B true CN114478670B (en) | 2024-01-30 |
Family
ID=81470915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011151383.4A Active CN114478670B (en) | 2020-10-27 | 2020-10-27 | A method for synthesizing On-DNA β-substituted ketone compounds |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114478670B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110041390A (en) * | 2019-04-26 | 2019-07-23 | 上海药明康德新药开发有限公司 | The synthetic method of the 1,2,3- 3-triazole compounds of On-DNA in DNA encoding compound library |
CN110359097A (en) * | 2019-07-08 | 2019-10-22 | 上海药明康德新药开发有限公司 | The method that On-DNA aromatic compound is obtained by Suzuki coupling reaction in the building of DNA encoding compound library |
CN110498822A (en) * | 2019-09-04 | 2019-11-26 | 上海药明康德新药开发有限公司 | The synthetic method of on-DNA aryl azide chemical combination object in the building of DNA encoding compound library |
CN110818749A (en) * | 2019-10-30 | 2020-02-21 | 上海药明康德新药开发有限公司 | Method for synthesizing On-DNA aryl sulfonamide compounds in construction of DNA coding compound library |
CN110820049A (en) * | 2019-10-30 | 2020-02-21 | 上海药明康德新药开发有限公司 | Method for synthesizing On-DNA aryl iodide in construction of DNA coding compound library |
-
2020
- 2020-10-27 CN CN202011151383.4A patent/CN114478670B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110041390A (en) * | 2019-04-26 | 2019-07-23 | 上海药明康德新药开发有限公司 | The synthetic method of the 1,2,3- 3-triazole compounds of On-DNA in DNA encoding compound library |
CN110359097A (en) * | 2019-07-08 | 2019-10-22 | 上海药明康德新药开发有限公司 | The method that On-DNA aromatic compound is obtained by Suzuki coupling reaction in the building of DNA encoding compound library |
CN110498822A (en) * | 2019-09-04 | 2019-11-26 | 上海药明康德新药开发有限公司 | The synthetic method of on-DNA aryl azide chemical combination object in the building of DNA encoding compound library |
CN110818749A (en) * | 2019-10-30 | 2020-02-21 | 上海药明康德新药开发有限公司 | Method for synthesizing On-DNA aryl sulfonamide compounds in construction of DNA coding compound library |
CN110820049A (en) * | 2019-10-30 | 2020-02-21 | 上海药明康德新药开发有限公司 | Method for synthesizing On-DNA aryl iodide in construction of DNA coding compound library |
Non-Patent Citations (1)
Title |
---|
Exploring Aldol Reactions on DNA and Applications to Produce Diverse Structures: An Example of Expanding Chemical Space of DNA-Encoded Compounds by Diversity-Oriented Synthesis;Rongfeng Wu等;chemistry an asian journal;第15卷(第23期);第4033-4037页 * |
Also Published As
Publication number | Publication date |
---|---|
CN114478670A (en) | 2022-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112837757B (en) | On-DNA Aldol reaction method in construction of DNA coding compound library | |
CN112830950B (en) | Method for synthesizing On-DNA (deoxyribonucleic acid) dihydrothiazole/thiazole compound | |
CN113004361B (en) | Method for synthesizing On-DNA pyrazole compound | |
CN113943979B (en) | A method for preparing On-DNA thioether compounds from On-DNA aryl halides | |
CN114478670B (en) | A method for synthesizing On-DNA β-substituted ketone compounds | |
CN112920245B (en) | Method for synthesizing On-DNA dihydropyrazole compound | |
CN112921405B (en) | Method for synthesizing On-DNA pyrazolo [1,5-a ] pyrimidine compound | |
CN112920246B (en) | Method for synthesizing On-DNA1,4-thiazepine compound | |
CN112851718A (en) | Method for constructing On-DNA alpha-amino amide compound by aqueous phase Ugi multi-component reaction | |
CN112920244B (en) | Method for synthesizing On-DNA pyrimidine compound | |
CN112851732B (en) | Method for synthesizing On-DNA 2-carboxyl-3-amino arylthiophene compound | |
CN110079867B (en) | On-DNA wittig reaction method in DNA coding compound library and prepared On-DNA olefin compound | |
CN112921406B (en) | Method for synthesizing On-DNA 2-aminopyrimidine compound | |
CN114075257B (en) | A kind of method that prepares arylamine compound by On-DNA aryl halide | |
CN105949136B (en) | A kind of synthetic method of 1,5- substitution -1,2,3- triazole compound | |
CN114411267B (en) | Method for constructing beta-aliphatic substituted ketone compound by On-DNA reaction | |
CN113563265B (en) | Method for synthesizing On-DNA N, N-monosubstituted indazolone compound | |
CN114057817B (en) | Method for preparing arylboronic acid from On-DNA aryl halide | |
CN112778380A (en) | Method for synthesizing On-DNA azide | |
CN116136032A (en) | A method for removing benzyl groups from DNA-encoded compounds | |
CN112175021B (en) | Method for synthesizing On-DNA aryl benzyl substituted compound | |
CN114957365A (en) | Method for synthesizing On-DNA gamma-aminoketone compound/tetrahydropyrrole compound | |
CN114957348B (en) | Method for synthesizing On-DNA (deoxyribonucleic acid) arylbenzotriazole compound and derivative thereof | |
CN116732617A (en) | A method for constructing C-N bonds by reacting On-DNA arylvinyl compounds with amines | |
CN112831843A (en) | A One-Pot On-DNA Suzuki Reaction Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |